Hematological Malignancies

Overall response rate: 09 study

June 2014

2% n=2

58%

10% n=12

8% n=10

Overall response n=72/125 (95% CI:

33% n=41

47% n=59

47% n=59

48.4– 66.4)

1% n=1*

Complete response

Partial response

Minor response

Stable disease

Progressive disease

Not evaluable

*LPL/WM patient